Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Marks

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Pharmacology, Biochemistry, and Behavior|May 1, 1984
Chronic scopolamine treatment and brain cholinergic functionM J Marks, M F O'Connor, L D Artman, et al.
Pharmacology, Biochemistry, and Behavior|August 1, 1981
Genetic influences on cholinergic drug responseM J Marks, D M Patinkin, L D Artman, et al.
Journal of the American Chemical Society|February 2, 1977
Optically active amines. 22. Application of the salicylidenimino chirality rule to alpha-amino acidsH E Smith, E P Burrows, M J Marks, et al.
Journal of Neurochemistry|December 1, 1994
Desensitization of nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomesM J Marks, S R Grady, J M Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomesY Lu, S Grady, M J Marks, et al.
Journal of Neurochemistry|June 1, 1991
Regulation of brain nicotinic receptors by chronic agonist infusionR V Bhat, S L Turner, S R Selvaag, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 1986
A genetic analysis of nicotine effects on open field activityM J Marks, L L Miner, S Cole-Harding, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levelsJ R Pauly, M J Marks, S F Robinson, et al.
Neuropharmacology|October 25, 2000
Nicotinic-agonist stimulated (86)Rb(+) efflux and [(3)H]epibatidine binding of mice differing in beta2 genotypeM J Marks, J A Stitzel, S R Grady, et al.
Genes, Brain, and Behavior|March 25, 2018
The interaction of the Chrna5 D398N variant with developmental nicotine exposureH C O'Neill, C R Wageman, S E Sherman, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Pharmacology, Biochemistry, and Behavior|May 1, 1984
Chronic scopolamine treatment and brain cholinergic functionM J Marks, M F O'Connor, L D Artman, et al.
Pharmacology, Biochemistry, and Behavior|August 1, 1981
Genetic influences on cholinergic drug responseM J Marks, D M Patinkin, L D Artman, et al.
Journal of the American Chemical Society|February 2, 1977
Optically active amines. 22. Application of the salicylidenimino chirality rule to alpha-amino acidsH E Smith, E P Burrows, M J Marks, et al.
Journal of Neurochemistry|December 1, 1994
Desensitization of nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomesM J Marks, S R Grady, J M Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomesY Lu, S Grady, M J Marks, et al.
Journal of Neurochemistry|June 1, 1991
Regulation of brain nicotinic receptors by chronic agonist infusionR V Bhat, S L Turner, S R Selvaag, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 1986
A genetic analysis of nicotine effects on open field activityM J Marks, L L Miner, S Cole-Harding, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levelsJ R Pauly, M J Marks, S F Robinson, et al.
Neuropharmacology|October 25, 2000
Nicotinic-agonist stimulated (86)Rb(+) efflux and [(3)H]epibatidine binding of mice differing in beta2 genotypeM J Marks, J A Stitzel, S R Grady, et al.
Genes, Brain, and Behavior|March 25, 2018
The interaction of the Chrna5 D398N variant with developmental nicotine exposureH C O'Neill, C R Wageman, S E Sherman, et al.
Pageof 11